Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
aggrenox
air transport
Alberta Stroke Program Early CT score
algorithm
andexanet
aneurysm, intracranial
angiography, neurologic complications with
angiotensin-converting enzyme, inhibitors
anterior cerebral artery, occlusion of
anticoagulant, complications of
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
antihypertensive
aptiganel
arterial dissection
arterial dissection, basilar
arterial dissection, carotid
arterial dissection, recurrent
arterial dissection, vertebral
arterial perforation
Asians
aspirin
aspirin, dose of
ataxia
atorvastatin
atrial fibrillation
atrial fibrillation, risk stratification
atrial myxoma
atypical
AURORA
baroreceptors
BASICS trial
basilar artery occlusion
basilar artery plaque
basilar artery stenosis
BASIS trial
BEST trial
blacks
blood pressure
blood pressure after stroke
brainstem, infarction of
brainstem, lesion of
call 911
cardioseal device
cardiovascular disease
carotid angiogram
carotid artery disease
carotid artery disease, medical management
carotid artery occlusion, intracranial
carotid artery occlusion, neck
carotid artery stenosis
carotid artery stenosis, intracranial
carotid-siphon stenosis
CASSISS trial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, contrast extravasation
CAT scan, dense artery sign
CAT scan, mismatch between cerebral blood volume/flow
CAT scan, mismatch between perfusion/diffusion
CAT scan, perfusion
cerebellar infarction
cerebral atherosclerosis
cerebral atherosclerosis, medical management
cerebral embolism
cerebral embolism, mechanical extraction
cerebral infarction
cerebral infarction, hemorrhagic
cerebral infarction, small, deep
cerebral ischemia
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, etiology
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, adolescent
cerebrovascular accident, age of lesion
cerebrovascular accident, anticoagulant treatment
cerebrovascular accident, awakening with
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, classification
cerebrovascular accident, complications with
cerebrovascular accident, cost of
cerebrovascular accident, delay in treatment
cerebrovascular accident, etiology
cerebrovascular accident, infancy and childhood
cerebrovascular accident, large
cerebrovascular accident, large ischemic core
cerebrovascular accident, nonarterial territory
cerebrovascular accident, nontreatment of
cerebrovascular accident, pathophysiology
cerebrovascular accident, platelet inhibiting drugs in treatment
cerebrovascular accident, prehospital screening
cerebrovascular accident, prehospital treatment
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, prognosis in
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, rehabilitation of
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, sex distribution
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, thromobolytic agents in treatment, early dramatic recovery
cerebrovascular accident, time of onset
cerebrovascular accident, time of presentation
cerebrovascular accident, time to treatment
cerebrovascular accident, unknown time of onset
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, treatment of
CHADS-VaSC score
CHANCE Trial
CHOICE trial
cholesterol
citicoline
clinical mismatch
Clinical Pathologic Conference(C.P.C.)
clinical trials
clopidogrel
CLOSURE I trial
clot retrieval
collateral circulation
color desaturation
coma
complications
controversies in neurology
coronavirus
cortical infarction, small
cortical vein thrombosis
cost
cost effectiveness
coumarin
COVID-19
craniectomy, decompressive
critical pathway
dabigatran
dabigatran, dose
DAWN stroke trial
decerebrate posture
DEFUSE study
dense basilar artery sign
dense middle cerebral artery sign
diplopia
dipyridamole
disability rating scale, neurological
disability, neurological
diuretic
dizziness
doll's head maneuver
door to imaging time
door to needle time
door to reperfusion time
door to treatment time
drop attacks
dural sinus thrombosis
dysarthria
edema, facial
efficacy
embolic stroke of unknown source
embolism
embolism, paradoxical
embolism, vertebral-basilar artery
emergencies, neurologic
emergency medical technicians
endarterectomy, carotid
endarterectomy, carotid-indications for
endovascular photoacoustic recanalization
endovascular therapy
endovascular therapy, late time window
endovascular therapy, selection criteria
endovascular therapy, time window
epidemic
epidemiology of neurology
EPITHET trial
ESCAPE trial
ethics in neurology
EXTEND trial
factor Xa inhibitor
failed medical management
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
fibroblast growth factor
gastrointestinal bleeding
gaze palsy
gender
GOLIATH trial
HAS-BLED score
head injury
headache
headache, thunderclap
hemorrhagic diathesis
heparin
heparin, low-molecular-weight
hepatic failure
heprain induced thrombocytopenia
HERMES
herpes simplex encephalitis, diagnosis of
hospital length of stay
hypercoagulable state
hyperintense vessel sign
hypertension
iatrogenic neurologic disorders
idarucizumab
indapamide
informed consent
INR value, time in range
INR values
internal carotid artery
intracerebral hemorrhage
intracranial hemorrhage
intracranial pressure, increased
ischemic core
ischemic penumbra
lawsuit
lipid lowering agent
lipids
liver disease
liver function enzymes
locked-in syndrome
malpractice
mastoiditis
MATCH trial
medical-legal aspects of neurology
MERCI trial
middle cerebral artery
middle cerebral artery atherosclerosis
middle cerebral artery territory infarction
middle cerebral artery, branch occlusion
middle cerebral artery, occlusion of
middle cerebral artery, stenosis of
misdiagnosis
mobile interventional stroke teams
mortality
MR CLEAN
MR WITNESS trial
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, FLAIR, hyperintense vessels
MRI, mismatch between DWI/FLAIR
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRI, volumetry
multimodal neuroimaging
neoplasm, intracranial-incidence and epidemiology of
neurologic consultation
neurologic disease, diagnoses of
neurologic examination, focal
neurologic recovery
neurologic signs
neurologic symptoms
neuroprotective agents
neuroradiology, interventional
NIH stroke scale
NMDA antagonists
non-vitamin K antagonist oral anticoagulants
nystagmus
old age, neurology of
outcome research
palliative care
patent foramen ovale
patent foramen ovale, percutaneous closure
patient information and support
patient selection
Penumbra System
perindopril
platelet inhibiting drugs
platelet inhibiting drugs, combined
POINT trial
pons, infarction of
posterior cerebral artery occlusion
posterior circulation stroke
practice guidelines
prevention of neurologic disorders
PROFESS trial
prognosis
PROGRESS trial
quality of life
ramipril
Rankin score
RAPID CT perfusion maps
recanalization, arterial
recanalization, venous
recurrent
rehabilitation for neurologic disorders
RELY trial
reperfusion
research
RESPECT trial
Retriever Device
REVASCAT trials
revascularization, surgical
review article
risk factors
risk factors, modification
risk-benefit assessment
rivaroxaban
ROCKET - AF trial
safety
screening
seizure
seizure, focal
serum alanine aminotransferase
solitaire device
SPARCL trial
SPORTIF trial
STARFlex septal closure system
statin therapy
stent, carotid artery
stent, coronary artery
stent, intracranial
stent, middle cerebral artery
stent, vertebral artery
streptokinase
stroke center
stroke disability scale
stroke protocol
stroke unit, mobile
subarachnoid hemorrhage
subdural hematoma
superior sagittal sinus thrombosis
SWIFT PRIME Trials
SWIFT trial
symptomatic
T lesion of MCA-ICA
telemedicine
teleneurology
telestroke
tenecteplase
thrombectomy
thrombectomy, distal occlusion
thrombin inhibitor
thromboaspiration
thrombolysis, mechanical
time is brain
TIMELESS trial
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, treatment of
transluminal angioplasty, basilar artery
transluminal angioplasty, carotid artery
transluminal angioplasty, intracranial
transluminal angioplasty, intracranial-indications for
transluminal angioplasty, middle cerebral artery
transluminal angioplasty, vertebral artery
transport of patient
trauma
treatment delay
treatment of neurologic disorder
Trevo retriever
trial design
unconsciousness
unconsciousness, transient
urokinase
vaccination, neurologic complications with
vaccine
vertebral artery
vertebral artery occlusion
vertebral artery stenosis
vertebral-basilar artery, atherosclerosis
vertebral-basilar artery, intraluminal clot
vertebral-basilar insufficiency
vertigo
vision, blurred
VISSIT trial
visual field defect
WAKE-UP trial
WASID trial
weakness, generalized
Wingspan study
workup
ximelagatran
Showing articles 1350 to 1400 of 2192 << Previous Next >>

Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000

Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000

Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000

How Well Does the Oxfordshire Community Stroke Project Classification Predict the Site and Size of the Infarct on Brain Imaging
JNNP 68:558-562,547, Mead,G.E.,et al, 2000

New magnetic Resonance Imaging Methods for Cerebrovascular Disease: Emerging Clinical Applications
Ann Neurol 47:559-570, Neumann-Haefelin,T.,et al, 2000

Yield of Diffusion-Weighted MRI for Detection of Potentially Relevant Findings in Stroke Patients
Neurol 54:1562-1567,1548,1549,1552, Albers,G.W.,et al, 2000

Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000

Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000

Treatment of Intraventricular Hemorrhage with Urokinase
Stroke 31:841-847, Naff,N.J.,et al, 2000

Stereotactic Computed Tomographic-Guided Aspiration and Thrombolysis of Intracerebral Hematoma
Stroke 31:834-840, Montes,J.M.,et al, 2000

Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000

Thrombolytic Reversal of Acute Human Cerebral Ischemic Injury Shown by Diffusion/Perfusion Magnetic Resonance imaging
Ann Neurol 47:462-469, Kidwell,C.S.,et al, 2000

Feasibility and Practicality of MR Imaging of Stroke in the Management of Hyperacute Cerebral Ischemia
AJNR 21:1184-1189, 1177, Schellinger,P.D. et al, 2000

Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000

Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000

Management of Cerebellar Infarction With Mass Effect
The Neurologist 6:172-176, Koh, M. et al, 2000

Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in patients at High Risk of Vascular Disease?
Stroke 31:1779-1784, Hankey,G.J. et al, 2000

Low-Molecular-Weight heparins and Heparinoids in Acute ischemic Stroke
Stroke 31:1770-1778, Bath,P.M.W. et al, 2000

Detection of Early CT Signs of >1/3 Middle Cerebral Artery Infarctions
Stroke 31:1667-1671, Kalafut,M.A. et al, 2000

Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000

Activation of Emergency Medical Services of Acute Stroke in a Nonurban Population
Stroke 31:1925-1928, Wein,T.H. et al, 2000

Pravastatin Therapy and The Risk of Stroke
NEJM 343:317-326, White,H.D. et al, 2000

Symptomatic Intracranial Atherosclerosis
Neurol 55:490-497, 465, Thijs,V.N. & Albers,G.W., 2000

Orolingual Angioneurotic Edema Following Therapy of Acute Ischemic Stroke with Alteplase
Neurol 55:599-600, Rudolf,J. et al, 2000

Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000

Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000

Alternative Strategies for Stroke Care: a Prospective Randomised Controlled Trial
Lancet 356:894-899,869, Kalra,L. et al, 2000

Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000

Statins and the Risk of Dementia
Lancet 356:1627-1631, Jick,H.,et al, 2000

Primary Stenting for High-Grade Basilar Artery Stenosis
AJNR 21:1744-1749, Phatouros,C.C.,et al, 2000

Thrombolytic Therapy in Patients with Acute Ischemic Stroke
Arch Neurol 57:1430-1436, Hinchey,J.A. & Benesch,C., 2000

Warfarin-Associated Hemorrhage and Cerebral Amyloid Angiopathy
Neurol 55:947-951, Rosand,J.,et al, 2000

Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000

Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000

Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000

Safety of Discontinuation of Anticoagulation in Patients with Intracranial Hemorrhage at High Thromboembolic Risk
Arch Neurol 57:1710-1713,1682, Phan,T.G.,et al, 2000

An Overview of Acute Stroke Therapy
Arch Int Med 160:3196-3206, Fisher,M. & Schaebitz,W., 2000

Early Stroke Treatment Associated with Better Outcome
Neurol 55:1649-1655, Marler,J.R.,et al, 2000

Effect of intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Stroke 31:2912-2919, The National Institute of Neurological Disorders a, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000

Subarachnoid Haemorrhage Treated with Anticoagulants
Lancet 356:1818, Ciccone,A.,et al, 2000

Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000

Can Emergency Department Physicians Safely and Effectively Initiate Thrombolysis for Acute Ischemic Stroke?
Neurol 55:1801-1805, Akins,P.T.,et al, 2000

Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI
Stroke 31:1318-1328, Schellinger,P.D.,et al, 2000

North Carolina Stroke Prevention and Treatment Facilities Survey
Stroke 31:66-70, Goldstein,L.B.,et al, 2000

Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000

AGGRENOX: A Combination of Antiplatelet Drugs for Stroke Prevention
The Medical Letter 442:11-12, , 2000

Identification of lacunar Infarcts Before Thrombolysis in the ECASS I Study
Neurol 54:684-688, Toni,D.,et al, 2000

rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000



Showing articles 1350 to 1400 of 2192 << Previous Next >>